For the purpose of these rules, the following definitions will
apply:
"AIDS" means the same as defined in Iowa Code
chapter 141A.
"Area quarantine" means the same as defined in
Iowa Code chapter 139A.
"Business" means the same as defined in Iowa
Code chapter 139A.
"Care provider" means the same as defined in
Iowa Code chapter 139A.
"Case" means an individual who has
confirmatory evidence of disease.
"Clinical laboratory" means any laboratory
performing analyses on specimens taken from the body of a person in order to
assess that person's health status.
"Communicable disease" means the same as
defined in Iowa Code chapter 139A.
"Congenital or inherited disorder" means any
congenital disorder as defined in Iowa Code chapter 136A or any inherited
disorder as defined in Iowa Code chapter 136A.
"Disease surveillance" means the ongoing,
systematic collection, analysis, and interpretation of health-related data
essential for planning, implementation, and evaluation of public health
programs and practices.
"Exposure" means contact with an agent in a
manner that could cause disease or infection.
"HBV" means the same as defined in Iowa Code
chapter 139A.
"Health care facility" means the same as
defined in Iowa Code chapter 139A.
"Health care provider" means the same as
defined in Iowa Code chapter 139A.
"HIV" means the same as defined in Iowa Code
chapter 141A.
"Hospital" means the same as defined in Iowa
Code chapter 135B.
"IDSS" means the Iowa disease surveillance
system, a secure electronic statewide disease reporting and surveillance
system.
"Infectious disease" means a disease caused by
the entrance into the body of organisms, including but not limited to bacteria,
protozoans, fungi, prions, or viruses that grow and multiply.
"Infectious tuberculosis" means pulmonary or
laryngeal tuberculosis as evidenced by:
1. Isolation of M. tuberculosis complex
(positive culture) from a clinical specimen or positive nucleic acid
amplification test, or
2. Both
radiographic evidence of tuberculosis, such as an abnormal chest X ray, CT, PET
or MRI scan, and clinical evidence, such as a positive skin test or whole blood
assay test for tuberculosis infection, coughing, sputum production, fever, or
other symptoms compatible with infectious tuberculosis that lead a health care
provider to diagnose infectious tuberculosis according to currently acceptable
standards of medical practice and to initiate treatment for
tuberculosis.
"Investigation" means an inquiry conducted to
determine the specific source, mode of transmission, and cause of a disease or
suspected disease occurrence and to determine the specific incidence,
prevalence, and extent of the disease in the affected or general population.
"Investigation" may also include the application of scientific methods and
analysis to institute appropriate control measures.
"Isolation" means the same as defined in Iowa
Code chapter 139A.
"Local board" means the same as defined in
Iowa Code chapter 139A.
"Local department" means the same as defined
in Iowa Code chapter 139A.
"Placard" means the same as defined in Iowa
Code chapter 139A.
"Poison control or poison information center"
means any organization or program that has as one of its primary objectives the
provision of toxicologic and pharmacologic information and referral services to
the public and to health care providers (other than pharmacists) in response to
inquiries about actual or potential poisonings.
"Public health disaster" means an incident as
defined in Iowa Code section
135.140.
"Quarantinable disease" means any communicable
disease that presents a risk of serious harm to public health and that may
require isolation or quarantine to prevent its spread. "Quarantinable disease"
includes but is not limited to cholera, diphtheria, infectious tuberculosis,
plague, smallpox, yellow fever, viral hemorrhagic fevers, novel influenza, and
severe acute respiratory syndrome (SARS).
"Quarantine" means the same as defined in Iowa
Code chapter 139A.
"Reportable cancers" means those cancers
included in the National Cancer Institute's Surveillance, Epidemiology and End
Results (SEER) Program.
"Reportable disease" means any disease or
condition approved by the state epidemiologist or medical director and
designated by this chapter.
"Sexually transmitted disease or infection" or
"STI" means a disease or infection as identified by this
chapter that is transmitted through sexual practices. "Sexually transmitted
disease or infection" includes but is not limited to acquired immunodeficiency
syndrome (AIDS), chlamydia, gonorrhea, hepatitis B, hepatitis C, human
immunodeficiency virus (HIV), human papillomavirus, and syphilis.
"Suspected case" means an individual who
presents with clinical signs or symptoms indicative of a reportable or
quarantinable disease.
"Toxic agent" means any noxious substance in
solid, liquid or gaseous form capable of producing illness in humans including
but not limited to pesticides as defined in Iowa Code chapter 206, heavy
metals, organic and inorganic dusts and organic solvents. Airborne toxic agents
may be in the form of dusts, fumes, vapors, mists, gases or
smoke.
